Akso Health Group (AHG)
0.8281
+0.08
(+10.41%)
USD |
NASDAQ |
May 01, 16:00
0.8281
0.00 (0.00%)
After-Hours: 20:00
Akso Health Group Enterprise Value: 8.396M for April 30, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 8.396M |
| April 29, 2024 | 9.144M |
| April 26, 2024 | 9.507M |
| April 25, 2024 | 8.853M |
| April 24, 2024 | 8.853M |
| April 23, 2024 | 10.46M |
| April 22, 2024 | 9.910M |
| April 19, 2024 | 13.88M |
| April 18, 2024 | 13.88M |
| April 17, 2024 | 11.83M |
| April 16, 2024 | 9.944M |
| April 15, 2024 | 9.768M |
| April 12, 2024 | 12.51M |
| April 11, 2024 | 14.23M |
| April 10, 2024 | 17.31M |
| April 09, 2024 | 17.09M |
| April 08, 2024 | 17.08M |
| April 05, 2024 | 20.06M |
| April 04, 2024 | 21.89M |
| April 03, 2024 | 21.66M |
| April 02, 2024 | 16.40M |
| April 01, 2024 | 17.32M |
| March 28, 2024 | 17.77M |
| March 27, 2024 | 16.63M |
| March 26, 2024 | 19.14M |
| Date | Value |
|---|---|
| March 25, 2024 | 14.80M |
| March 22, 2024 | 18.69M |
| March 21, 2024 | 18.69M |
| March 20, 2024 | 19.95M |
| March 19, 2024 | 19.83M |
| March 18, 2024 | 20.29M |
| March 15, 2024 | 14.11M |
| March 14, 2024 | 20.74M |
| March 13, 2024 | 20.29M |
| March 12, 2024 | 23.03M |
| March 11, 2024 | 23.03M |
| March 08, 2024 | 20.74M |
| March 07, 2024 | 22.12M |
| March 06, 2024 | 21.43M |
| March 05, 2024 | 19.37M |
| March 04, 2024 | 20.97M |
| March 01, 2024 | 23.03M |
| February 29, 2024 | 22.34M |
| February 28, 2024 | 23.03M |
| February 27, 2024 | 23.26M |
| February 26, 2024 | 23.26M |
| February 23, 2024 | 21.20M |
| February 22, 2024 | 18.00M |
| February 21, 2024 | 18.46M |
| February 20, 2024 | 21.66M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-2.656M
Minimum
Dec 28 2022
426.02M
Maximum
Oct 20 2021
30.23M
Average
23.78M
Median
May 06 2020
Enterprise Value Benchmarks
| Universe Pharmaceuticals Inc | -4.572M |
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | 19.67M |
| Zai Lab Ltd | 770.97M |
| I-MAB | -174.63M |
Enterprise Value Related Metrics
| Earnings Yield | -28.98% |
| Normalized Earnings Yield | -94.69 |